Glasgow, United Kingdom; 22nd October 2018: Sistemic Ltd. is pleased to announce the completion of a Global Service and License Agreement for its SistemPSCCheck™ assay with Australian stem cell and regenerative medicine company, Cynata Therapeutics Ltd. The agreement will see the use of the SistemPSCCheck™ assay for the assessment of residual pluripotent stem cells in Cynata’s current iPSC-derived MSC clinical candidate CYP-001, as well other planned iPSC-derived MSC products.
We are looking for 2 life sciences graduates to support development of our new SistemPSCCheck™ v1.0 service product. These are 12 month placements, with the potential to develop into a permanent roles. For full information, please visit Scotgrad via the links below:
Sistemic will be attending the 4th Cell Therapy Conference: Manufacturing and Testing of Pluripotent Stem Cells in June to highlight the development of SistemPSCCheck™ - the world’s first commercial assay for assessment of pluripotent stem cell contamination in derived cell therapy products
GLASGOW, SCOTLAND Sistemic will be attending Phacilitate Cell & Gene Therapy World and the World Stem Cell Summit in January to highlight the development of their assay for assessment of pluripotent stem cell contamination in derived cell therapy products
Glasgow, SCOTLAND. Sistemic Ltd. is excited to announce significant progress with the development of a miRNA-based assay for assessment of pluripotent stem cell (PSC) contamination in derived cell therapy products. The development is being undertaken in conjunction with LGC, the UK National Measurement Laboratory and Designated Institute for chemical and bio-measurement.
We are attending this years fourth annual Cell Therapy Conference to talk about SistemPSCCheck: https://t.co/l1JzaLJPBw —
Tweeted:Mon, 06/04/2018 - 22:02
Meet us at Phacilitate Cell & Gene Therapy World and the World Stem Cell Summit to discuss our assay for assessment… https://t.co/bcZLrYWdSG —
Tweeted:Wed, 01/17/2018 - 16:23
We will be attending this years @alliancerm 2017 Cell & Gene Meeting on the Mesa - DM for partnering information! #mesa17 —
Tweeted:Tue, 10/03/2017 - 10:36
We are recruiting! New Bioinformatician / Biostatistician role available working with us in our Glasgow offices. https://t.co/klWWQGQfE4 —
Tweeted:Tue, 06/13/2017 - 10:59
We will be attending this years # #ISCT2017 meeting in London on the 4th of May. DM/Email for partnering. #CellTherapy —
Tweeted:Tue, 04/18/2017 - 11:27
Publication on potential for patient stratification using a cell-based therapy for refractory rheumatoid arthritis.… https://t.co/545Zo8QHxR —
Tweeted:Mon, 01/09/2017 - 14:02
Sistemic announce new publication and expansion of patent portfolio in the exosome and predictive biomarker space.… https://t.co/ayjOAy3glm —
Tweeted:Wed, 10/05/2016 - 16:35
We would like to thank all of our customers, collaborators and friends for another product year. Happy Holidays! https://t.co/ZxWA0Tcjm4 —
Tweeted:Wed, 12/16/2015 - 16:21
We will be attending this years World Stem Cells & Regenerative Medicine Congress - email or DM to arrange a meeting. #WSCRM#celltherapy —
Tweeted:Thu, 05/14/2015 - 11:46
Our principal scientist Dr David Mallinson will be attending the Extracellular Biomarker Summit next week. Contact us for info #biomarkers —
Tweeted:Wed, 03/11/2015 - 17:10
RT @ScotDevInt: A great example of life sciences collaboration: @Sistemic and @RoslinCells to work together on iPSC characterisation http:/… —
Tweeted:Tue, 01/27/2015 - 13:20
RT @ScotDevInt: Want to characterise your cells? Stop by our booth at #SCMOM14 to meet microRNA specialists @Sistemic —
Tweeted:Wed, 10/08/2014 - 09:20
Dr Daria Olijnyk will be in attendance at this years Stem Cells Meeting On the Mesa – get in touch to arrange partnering. #SCMOM14 —
Tweeted:Mon, 10/06/2014 - 13:27
RT @scotent: .@TCBioPharm have completed a clinical manufacturing facility in Glasgow with help from the Scottish Investment Bank http://t.… —
Tweeted:Thu, 10/02/2014 - 15:24
We're presenting two posters (#290 and #385) at this years #ISCT meeting. We hope to see you there! http://t.co/6AoJ6ZYr5I —
Tweeted:Tue, 04/22/2014 - 15:34
We're arranging partnering for #isct 2014 - to learn about miRNA utility in CT prod. development contact us or visit our posters! (290, 385) —
Tweeted:Mon, 04/14/2014 - 16:40
NHS Scotland and Sistemic Collaborate to develop novel early diagnostics for Diabetic sight loss http://t.co/u5yNsM1dCd#diabetes#mirna RT —
Tweeted:Tue, 10/29/2013 - 18:12
As #StemCells Meeting on the Mesa 2013 draws to an end we would just like to thank everyone for the enjoyable and productive week! #SCMOM13 —
Tweeted:Fri, 10/18/2013 - 16:40
Here's another infographic showing the key points of our recently announced collaboration with QCMD! #SCMOM13http://t.co/D63mTOCbCL —
Tweeted:Wed, 10/16/2013 - 17:03
We're excited to announce collab between Sistemic and QCMD aimed at ensuring standards in #celltherapy. Full story: http://t.co/1NAM9m7Oc6 —
Tweeted:Wed, 10/16/2013 - 14:53
If you missed our earlier announcements then here's a quick recap in infographic form: #SCMOM13 RT http://t.co/axJG940thO —
Tweeted:Tue, 10/15/2013 - 16:55
Our new partnership with @RoslinCells helps make Scotland the best destination for CT clinical trials. Full story: http://t.co/4Lp0crUexR —
Tweeted:Tue, 10/15/2013 - 11:31
We will be attending the Regenerative Medicine Manufacturing Industrial Summit on the 13th of September. Hope to see you there! —
Tweeted:Thu, 09/12/2013 - 11:41
Sistemic is delighted to be attending ISSCR. Come and see us on the 12th of June at the poster W-2046 or ask for us at the SDI booth! —
Tweeted:Wed, 06/12/2013 - 00:32
